Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Zalupski

Showing results (1-10 of 124) with videos related to

Pageof 13
Sort By:
Journal of the National Cancer Institute|June 15, 1988
IfosfamideM Zalupski, L H Baker
Monographs in Pathology|January 1, 1996
Sarcomas: the role of adjuvant chemotherapy and a proposed new staging systemL H Baker, M Zalupski
Cancer|January 24, 2023
Reply to "Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?"Vaibhav Sahai, Mark M Zalupski
International Journal of Radiation Oncology, Biology, Physics|June 27, 2003
Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trialsCornelius J McGinn, Mark M Zalupski
Journal of Surgical Oncology|November 10, 2011
Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinibEdward J Kim, Mark M Zalupski
Hematology/Oncology Clinics of North America|August 1, 1995
Systemic adjuvant chemotherapy for soft tissue sarcomasM M Zalupski, L H Baker
Cancer Journal (Sudbury, Mass.)|September 20, 2001
Combined-modality therapy in pancreatic cancer: current status and future directionsC J McGinn, M M Zalupski
The Journal of Infusional Chemotherapy|January 1, 1995
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomasM M Zalupski, L H Baker
American Journal of Clinical Oncology|December 10, 1997
The heterogeneity of leukemia occurring after treatment for sarcomaM Varterasian, M Zalupski, C Karanes
Cancer Investigation|January 1, 1996
GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group studyL G Hicks, S P Balcerzak, M Zalupski
Pageof 13

Showing results (1-10 of 124) with videos related to

Sort By:
Pageof 13
Journal of the National Cancer Institute|June 15, 1988
IfosfamideM Zalupski, L H Baker
Monographs in Pathology|January 1, 1996
Sarcomas: the role of adjuvant chemotherapy and a proposed new staging systemL H Baker, M Zalupski
Cancer|January 24, 2023
Reply to "Is there a role for combined anti-PD-1/CTLA-4 checkpoint blockade in the management of advanced biliary tract cancers?"Vaibhav Sahai, Mark M Zalupski
International Journal of Radiation Oncology, Biology, Physics|June 27, 2003
Radiation therapy with once-weekly gemcitabine in pancreatic cancer: current status of clinical trialsCornelius J McGinn, Mark M Zalupski
Journal of Surgical Oncology|November 10, 2011
Systemic therapy for advanced gastrointestinal stromal tumors: beyond imatinibEdward J Kim, Mark M Zalupski
Hematology/Oncology Clinics of North America|August 1, 1995
Systemic adjuvant chemotherapy for soft tissue sarcomasM M Zalupski, L H Baker
Cancer Journal (Sudbury, Mass.)|September 20, 2001
Combined-modality therapy in pancreatic cancer: current status and future directionsC J McGinn, M M Zalupski
The Journal of Infusional Chemotherapy|January 1, 1995
Low-dose, continuous infusion 5-fluorouracil and oral etoposide for the treatment of advanced sarcomasM M Zalupski, L H Baker
American Journal of Clinical Oncology|December 10, 1997
The heterogeneity of leukemia occurring after treatment for sarcomaM Varterasian, M Zalupski, C Karanes
Cancer Investigation|January 1, 1996
GM-CSF did not allow doxorubicin dose escalation in the MAID regimen: a phase I trial. A Southwest Oncology Group studyL G Hicks, S P Balcerzak, M Zalupski
Pageof 13